Plasma endothelin-1 levels in patients with complex regional pain syndrome

European Journal of Pain

Volumn 8, Issue 6, 2004, Pages 533-538

  Eisenberg, Elon ^a   Erlich, Tomer ^a   Zinder, Oren ^a   Lichinsky, Sophie ^a   Diamond, Eric ^a   Pud, Dorit ^b   Davar, Gudarz ^c  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b UNIVERSITY OF HAIFA   (Israel)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Allodynia; Neuropathic pain; Sudomotor; Vasomotor

Indexed keywords

BIOLOGICAL MARKER; ENDOTHELIN 1;

ADULT; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; COMPLEX REGIONAL PAIN SYNDROME; CONTROLLED STUDY; FEMALE; HUMAN; MALE; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

ADULT; COMPLEX REGIONAL PAIN SYNDROMES; ENDOTHELIN-1; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FUNCTIONAL LATERALITY; HUMANS; MALE; PAIN MEASUREMENT; PAIN THRESHOLD; QUESTIONNAIRES;

EID: 8644247669     PISSN: 10903801     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejpain.2003.12.003     Document Type: Article

References (34)

1. Baron R, Blumberg H, Janig W. Clinical characteristics of patients with complex regional pain syndrome in Germany with special emphasis on vasomotor function. Reflex sympathetic dystrophy: a reappraisal. IASP; 1996. p. 25-48
2. Bruehl S., Harden R.N., Galer B.S., et al. External validation of IASP diagnostic criteria for complex regional pain syndrome and proposed research diagnostic criteria. Pain. 81:1999;147-154
3. Carducci M.A., Nelson J.B., Bowling M.K., et al. Atrasentan, an endothelin-receptor antagonist for refractory adenocarcinomas: safety and pharmacokinetics. J. Clin. Oncol. 20:2002;2171-2180
4. Dahlof B., Gustafsson D., Hedner T., Jern S., Hansson L. Regional haemodynamic effects of endothelin-1 in rat and man: unexpected adverse reactions. J. Hyperten. 8:1990;811-817
5. Davar G., Hans G., Fareed M.U., Sinnott C., Strichartz G. Behavioral signs of acute pain produced by application of endothelin-1 to rat sciatic nerve. NeuroReport. 13(9):1998;2279-2283
6. De-Melo J.D., Tonussi C.R., D'Orleans-Juste P., Rae G.A. Effects of endothelin-1 on inflammatory incapacitation of the rat knee joint. J. Cardiovasc. Pharmacol. 31(Suppl 1):1998;S518-520
7. Ferreira S.H., Romitelli M., de Nucci G. Endothelin-1 participation in overt and inflammatory pain. J. Cardiovasc. Pharmacol. 13(Suppl 5):1989;S220-222
8. Frej F., Outi S., Kaj M., Ilkka T., Katarina R., Tuula T. Raised plasma endothelin-1 concentration following cold pressor test. Biochem. Biophys. Res. Commun. 169:1990;217-221
9. Fareed U.M., Guy H.H., Alfred A., Gary J., Strichartz R., Davar G. Phrmacological characterization of acute pain behavior produced by application of endothelin-1 to rat sciatic nerve. Pain. 1:2000;46-53
10. Gokin A.P., Fareed M.U., Pan H.L., Hans G., Strichartz G.R., Davar G. Local injection of endothelin-1 produces pain-like behavior and excitation of nociceptors in rats. J. Neurosci. 21:2001;5358-5366
11. Graido-Gonzalez E., Doherty J.C., Bergreen E.W., Organ G., Telfer M., McMillen M.A. Plasma endothelin-1, cytokine, and prostaglandin E2 levels in sickle cell disease and acute vaso-occlusive sickle crisis. Blood. 1(92):1998;2551-2555
12. Jarvis M.F., Wessale J.L., Zhu C.Z., et al. ABT-627 an endothelin ET(A) receptor-selective antagonist, attenuates tactile allodynia in a diabetic rat model of neuropathic pain. Eur. J. Pharmacol. 388:2000;29-35
13. Kahler J., Mendel S., Weckmuller J., et al. Oxidative stress increases synthesis of big endothelin-1 by activation of the endothelin-1 promoter. J. Mol. Cell Cardiol. 32:2000;1429-1437
14. Klass M., Hord A., Wilcox M., Csete M. Expression patterns of endothelin (ET) and its receptors after chronic constriction injury. Am. Soc. Anesthesiol. Annual Meeting A. 946:2003;279
15. Mangiafico R.A., Malatino L.S., Spada R.S., et al. Treadmill exercise-induced release of endothelin-1 in patients with peripheral arterial occlusive disease at Fontaine stage IIb. Int. Angiol. 19:2000;14-17
16. Melzack R. The McGill Pain Questionnaire: major properties and scoring methods. Pain. 1:1975;277-299
17. Michelakakis N.A., Petropoulou E.N., Lazaros G.A., et al. Comparison of endothelin-1 levels at rest and during exercise between patients with cardiac syndrome-X and healthy people. Acta Cardiol. 53:1998;3-6
18. Nelson J.B., Hedican S.P., George D.J., et al. Identification of endothelin-1 in the pathophysiology of metastatic adenocarcinoma of the prostate. Nat. Med. 1:1995;944-949
19. Oda M., Han J.Y., Nakamura M. Endothelial cell dysfunction in microvasculature: relevance to disease processes. Clin. Hemorheol. Microcirc. 23:2000;199-211
20. Piovezan A.P., D'Orleans-Juste P., Souza G.E., Rae G.A. Endothelin-1-induced ET(A) receptor-mediated nociception, hyperalgesia and oedema in the mouse hind-paw: modulation by simultaneous ET(B) receptor activation. Br. J. Pharmacol. 129:2000;961-968
21. Piovezan A.P., D'Orleans-Juste P., Tonussi C.R., Rae G.A. Effects of endothelin-1 on capsaicin-induced nociception in mice. Eur. J. Pharmacol. 351:1998;15-22
22. Piovezan A.P., D'Orleans-Juste P., Tonussi C.R., Rae G.A. Endothelins potentiate formalin-induced nociception and paw edema in mice. Can. J. Physiol. Pharmacol. 75:1997;596-600
23. Price D.D., McGrath P.A., Rafii A., Buckingham B. The validation of visual analogue scales as ratio scale measures for chronic and experimental pain. Pain. 17:1983;45-56
24. Raffa R.B., Schupsky J.J., Jacobi H.I. Endothelin-induced nociception in mice: mediation by ETA and ETB receptors. J. Pharmacol. Exp. Ther. 276:1996;647-651
25. Rossi G.P., Seccia T.M., Albertin G., Pessina A. Measurement of endothelin: clinical and research use. Ann. Clin. Biochem. 37:2000;608-626
26. Stanton-Hicks M., Janig W., Hassenbusvh S., Haddox J.D., Boas R., Wilson P. Reflex sympathetic dystrophy: chancing concepts and taxonomy. Pain. 63:1995;127-133
27. Tsutamoto T., Wada A., Maeda K., et al. Transcardiac extraction of circulating endothelin-1 across the failing heart. Am. J. Cardiol. 86:2000;524-528
28. Wagner O.F., Christ G., Wojta J., Vierhapper H., Parzer S., Nowotny P.J., et al. Polar secretion of endothelin-1 cultured endothelial cells. J. Biol. Chem. 267:1992;16066-16068
29. Yanagisawa M., Kurihara H., Kimura S., et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 332:1998;411-415
30. Yarnitsky D., Fowler C. Quantitative Thermal testing. Osselton J.W. Clinical Neurophysiology. 1995;253-270 Oxford, Butterworth-Heinemann
31. Yokokawa K., Tahara H., Kohno M., et al. Endothelin-secreting tumor. Cardiovasc. Pharmacol. 17:1991;S398-401
32. Yoshimoto S., Ishizaki Y., Sasaki T., Murota S. Effects on carbon dioxide and oxygen on endothelin production by cultured procine cerebral endothelial cells. Stroke. 22:1991;378-383
33. Zhou Z., Davar G., Strichartz G. Endothelin-1 ET-1 selectively enhances the activation gating of slowly inactivating tetrodotoxin-resistant sodium currents in rat sensory neurons: a mechanism for the pain-inducing actions of ET-1. J. Neurosci. 22:2002;6325-6330
34. A receptors to increase intracellular calcium in model sensory neurons. NeuroReport. 12:2001;3853-3856